These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 12771800
1. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. Azuma H, Takahara S, Horie S, Muto S, Otsuki Y, Katsuoka Y. J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800 [Abstract] [Full Text] [Related]
2. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, Gotoh R, Okuyama A, Suzuki S, Katsuoka Y, Takahara S. Anticancer Res; 2003 Jun; 23(4):3183-93. PubMed ID: 12926052 [Abstract] [Full Text] [Related]
3. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y. Anticancer Res; 2007 Jun; 27(1A):75-88. PubMed ID: 17352219 [Abstract] [Full Text] [Related]
4. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, Morimoto J, Fukui R, Hoshiga M, Ishihara T, Nonomura N, Suzuki S, Okuyama A, Katsuoka Y. Cancer Res; 2002 Mar 01; 62(5):1410-9. PubMed ID: 11888913 [Abstract] [Full Text] [Related]
5. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway. Matsuda S, Minowa A, Suzuki S, Koyasu S. J Immunol; 1999 Mar 15; 162(6):3321-6. PubMed ID: 10092785 [Abstract] [Full Text] [Related]
6. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance. Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, Catley L, Mitsiades CS, Richardson PG, Albert R, Brinkmann V, Chauhan D, Anderson KC. Cancer Res; 2005 Aug 15; 65(16):7478-84. PubMed ID: 16103102 [Abstract] [Full Text] [Related]
7. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells. Shen Y, Cai M, Xia W, Liu J, Zhang Q, Xie H, Wang C, Wang X, Zheng S. Cancer Lett; 2007 Sep 08; 254(2):288-97. PubMed ID: 17462818 [Abstract] [Full Text] [Related]
8. FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells. Sonoda Y, Yamamoto D, Sakurai S, Hasegawa M, Aizu-Yokota E, Momoi T, Kasahara T. Biochem Biophys Res Commun; 2001 Feb 23; 281(2):282-8. PubMed ID: 11181042 [Abstract] [Full Text] [Related]
9. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism. Du Z, Hou S. J Urol; 2003 Nov 23; 170(5):2000-3. PubMed ID: 14532841 [Abstract] [Full Text] [Related]
10. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O. Cancer Res; 2010 Nov 01; 70(21):8651-61. PubMed ID: 20959468 [Abstract] [Full Text] [Related]
11. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo. Nagasawa J, Mizokami A, Koshida K, Yoshida S, Naito K, Namiki M. Int J Urol; 2006 May 01; 13(5):587-92. PubMed ID: 16771730 [Abstract] [Full Text] [Related]
12. MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer. Zhu Y, Jiang H, Zhang C, He QJ, Yang B, Li LJ, Zhu H. Pharmazie; 2009 Dec 01; 64(12):823-8. PubMed ID: 20095141 [Abstract] [Full Text] [Related]
13. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Xiao D, Pinto JT, Soh JW, Deguchi A, Gundersen GG, Palazzo AF, Yoon JT, Shirin H, Weinstein IB. Cancer Res; 2003 Oct 15; 63(20):6825-37. PubMed ID: 14583480 [Abstract] [Full Text] [Related]
14. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL, Chen CS. Cancer Res; 2008 Feb 15; 68(4):1204-12. PubMed ID: 18281497 [Abstract] [Full Text] [Related]
15. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK. Small GW, Somasundaram S, Moore DT, Shi YY, Orlowski RZ. J Pharmacol Exp Ther; 2003 Dec 15; 307(3):861-9. PubMed ID: 14557375 [Abstract] [Full Text] [Related]
16. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells. Sakamoto H, Mashima T, Sato S, Hashimoto Y, Yamori T, Tsuruo T. Clin Cancer Res; 2001 Aug 15; 7(8):2513-8. PubMed ID: 11489834 [Abstract] [Full Text] [Related]
17. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. Lee TK, Man K, Ho JW, Sun CK, Ng KT, Wang XH, Wong YC, Ng IO, Xu R, Fan ST. Carcinogenesis; 2004 Dec 15; 25(12):2397-405. PubMed ID: 15297371 [Abstract] [Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S. J Rheumatol; 2002 Apr 15; 29(4):707-16. PubMed ID: 11950011 [Abstract] [Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
20. Caveolin-1 acts as a tumor suppressor by down-regulating epidermal growth factor receptor-mitogen-activated protein kinase signaling pathway in pancreatic carcinoma cell lines. Han F, Gu D, Chen Q, Zhu H. Pancreas; 2009 Oct 15; 38(7):766-74. PubMed ID: 19893453 [Abstract] [Full Text] [Related] Page: [Next] [New Search]